Gillanders Arbuthnot Peer Comparison

NSE: GILLANDERS | BSE: 532716

₹99.50

₹-3.14 (-3.06%)

As on 21-Oct-2026 13:12IST

Market cap

₹216 Cr

Revenue (TTM)

₹434 Cr

P/E Ratio

12.4

P/B Ratio

0.8

Div. Yield

0 %

Edit

	Gillanders Arbuthnot	KEC International	Tamboli Capital	Delta Manuf	Indrayani Biotech
Market cap (₹ Cr)	216	9,059	342	67	38
Revenue (₹ Cr)	434	23,506	82	67	181
Net Profit (₹ Cr)	17.44	553.62	10.62	-7.30	2.66
Net Margin (%)	3.90	2.35	12.59	0.51	1.42
RoE (%)	6.80	10.18	9.30	-47.21	2.82
Price to Earnings	12.39	16.36	32.21	--	18.26
Price-To-Book	0.83	1.45	2.75	27.36	0.52

Income Statement (₹ Cr)

	Gillanders Arbuthnot	KEC International	Tamboli Capital	Delta Manuf	Indrayani Biotech
Operating Revenue	430.87	23,505.54	80.43	61.87	130.23
Total Income	442.48	23,662.81	83.18	63.37	133.35
Total Expenditure	407.51	21,745.77	64.21	57.54	123.85
EBITDA	23.37	1,759.77	16.22	4.33	6.38
Depreciation	10.92	197.38	4.38	2.76	3.37
EBIT	12.45	1,562.39	11.84	1.57	3.01
Interest	12.97	871.74	0.56	0.79	11.88
Other Income	11.60	157.27	2.75	1.50	3.13
Exceptional Items	11.95	-58.78	-0.60	0.09	--
Profit before Tax	11.08	789.14	13.44	-0.99	-5.74
Provision for Tax	1.61	183.55	3.63	0.08	0.36
Profit after Tax	9.47	605.59	9.81	-1.06	-6.11

	Gillanders Arbuthnot	KEC International	Tamboli Capital	Delta Manuf	Indrayani Biotech
Shareholder's Funds	257.94	6,159.69	122.45	2.31	72.51
Minority Interest	--	--	--	--	27.41
Non-Current Liabilities	68.01	515.16	2.31	8.14	65.54
Current Liabilities	236.55	18,007.82	9.40	55.00	102.48
Total Liabilities	567.57	25,133.45	134.69	68.45	267.94

	Gillanders Arbuthnot	KEC International	Tamboli Capital	Delta Manuf	Indrayani Biotech
Non-Current Assets	313.41	2,473.59	75.09	39.29	90.00
Current Assets	249.09	22,209.08	59.07	26.27	177.94
Total Assets	567.57	25,133.45	134.69	68.45	267.94
Total Debt*	148.60	5,103.23	2.43	39.12	137.07
Net Current Assets	12.55	4,201.26	49.67	-28.73	75.45
Contingent Liabilities	16.95	188.22	2.67	4.61	--

	Gillanders Arbuthnot	KEC International	Tamboli Capital	Delta Manuf	Indrayani Biotech
Cash From Operating Activities	14.25	-414.12	12.08	0.66	-6.74
Cash Flow from Investing Activities	-8.24	-241.80	-10.09	-9.76	24.74
Cash from Financing Activities	-3.75	510.97	-5.36	9.44	-18.30
Net Cash Inflow / Outflow	2.26	-144.95	-3.37	0.34	-0.29

	Gillanders Arbuthnot	KEC International	Tamboli Capital	Delta Manuf	Indrayani Biotech
ROCE (%)	6.08	16.35	11.43	-0.48	3.19
ROE (%)	3.76	10.53	8.31	-12.57	-9.25
ROA (%)	1.74	2.61	7.52	-1.56	-2.44
EBIT Margin (%)	8.12	8.16	23.59	9.42	7.30
Net Margin (%)	2.14	2.56	11.79	-1.68	-4.58
Cash Profit Margin (%)	4.72	3.42	17.64	2.75	-2.10

	Gillanders Arbuthnot	KEC International	Tamboli Capital	Delta Manuf	Indrayani Biotech
Revenue Growth (%)	-2.78	7.59	16.72	10.80	-21.66
EBIT Growth (%)	-3.51	9.54	18.11	33.58	-61.80
Net Profit Growth (%)	-64.58	6.11	27.10	-250.62	-158.60
EPS Growth (%)	-64.58	6.11	27.10	-2.64	-124.45
Book Value Growth (%)	5.20	15.19	7.79	-84.21	9.39

	Gillanders Arbuthnot	KEC International	Tamboli Capital	Delta Manuf	Indrayani Biotech
Price / Earnings	18.22	22.49	13.36	0.00	0.00
Price / Book Value	0.67	2.21	1.07	21.65	0.94
Dividend Yield (%)	0.00	1.08	0.91	0.00	0.00
EV/EBITDA	9.09	9.50	6.00	15.18	21.23
Market Cap (₹ Cr)	172.48	13,619.11	131.05	49.91	64.93

	Gillanders Arbuthnot	KEC International	Tamboli Capital	Delta Manuf	Indrayani Biotech
Debt to Equity	0.58	0.83	0.02	16.97	1.99
Short term debt to equity ratio	0.41	0.68	0.03	14.97	0.97
Current Ratio	1.05	1.23	6.28	0.48	1.74
Quick Ratio	0.60	1.15	4.84	0.33	1.33
Interest Coverage	1.85	1.91	25.20	-0.25	0.52

	Gillanders Arbuthnot	KEC International	Tamboli Capital	Delta Manuf	Indrayani Biotech
Debtors to sales (%)	14.66	27.54	27.55	19.80	45.07
Asset Turnover	0.80	1.01	0.62	0.91	0.52
Receivable days	52.78	89.48	87.30	79.88	137.64
Inventory Days	83.71	20.76	61.62	57.53	117.29
Payable days	179.84	238.84	135.35	149.50	134.44
Cash Conversion Cycle	-43.36	-128.60	13.57	-12.09	120.49

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.